[go: up one dir, main page]

NO20016069D0 - Nye bicykliske amino-pyrazinonforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdendedem - Google Patents

Nye bicykliske amino-pyrazinonforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdendedem

Info

Publication number
NO20016069D0
NO20016069D0 NO20016069A NO20016069A NO20016069D0 NO 20016069 D0 NO20016069 D0 NO 20016069D0 NO 20016069 A NO20016069 A NO 20016069A NO 20016069 A NO20016069 A NO 20016069A NO 20016069 D0 NO20016069 D0 NO 20016069D0
Authority
NO
Norway
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
novel bicyclic
bicyclic amino
Prior art date
Application number
NO20016069A
Other languages
English (en)
Other versions
NO20016069L (no
NO322149B1 (no
Inventor
Guillaume De Nanteuil
Philippe Gloanec
Tony Verbeuren
Alain Rupin
Marie-Odile Vallez
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of NO20016069D0 publication Critical patent/NO20016069D0/no
Publication of NO20016069L publication Critical patent/NO20016069L/no
Publication of NO322149B1 publication Critical patent/NO322149B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO20016069A 2000-12-14 2001-12-12 Nye bicykliske amino-pyrazinonforbindelser, fremgangsmate ved deres fremstilling og farmasoytiske sammensetninger inneholdende dem NO322149B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0016321A FR2818277B1 (fr) 2000-12-14 2000-12-14 Nouveaux derives bicycliques d'amino-pyrazinones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (3)

Publication Number Publication Date
NO20016069D0 true NO20016069D0 (no) 2001-12-12
NO20016069L NO20016069L (no) 2002-06-17
NO322149B1 NO322149B1 (no) 2006-08-21

Family

ID=8857662

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20016069A NO322149B1 (no) 2000-12-14 2001-12-12 Nye bicykliske amino-pyrazinonforbindelser, fremgangsmate ved deres fremstilling og farmasoytiske sammensetninger inneholdende dem

Country Status (24)

Country Link
US (1) US6686358B2 (no)
EP (1) EP1215213B1 (no)
JP (1) JP3616599B2 (no)
KR (1) KR100502251B1 (no)
CN (1) CN1209363C (no)
AR (1) AR031662A1 (no)
AU (1) AU781614B2 (no)
BR (1) BR0106129A (no)
CA (1) CA2364199C (no)
CY (1) CY1106376T1 (no)
DE (1) DE60126046T2 (no)
DK (1) DK1215213T3 (no)
EA (1) EA004678B1 (no)
ES (1) ES2280333T3 (no)
FR (1) FR2818277B1 (no)
HK (1) HK1047101B (no)
HU (1) HUP0105328A3 (no)
MX (1) MXPA01012895A (no)
NO (1) NO322149B1 (no)
NZ (1) NZ516129A (no)
PL (1) PL351199A1 (no)
PT (1) PT1215213E (no)
SI (1) SI1215213T1 (no)
ZA (1) ZA200110314B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040077605A1 (en) * 2001-06-20 2004-04-22 Salvati Mark E. Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
EP1854798A3 (en) * 2000-09-19 2007-11-28 Bristol-Myers Squibb Company Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
US20040087548A1 (en) 2001-02-27 2004-05-06 Salvati Mark E. Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
AU2002364082A1 (en) * 2001-12-19 2003-07-09 Bristol-Myers Squibb Company Fused heterocyclic compounds and analogs thereof: modulators of nuclear hormone receptor function
EP1523483A4 (en) * 2002-06-26 2006-03-08 Bristol Myers Squibb Co AMINO-BICYCLIC PYRAZINONE AND PYRIDINONE FOR INHIBITING THE COOKING OF SERIN PROTEASE
FR2867780B1 (fr) * 2004-03-19 2006-05-19 Servier Lab Nouveaux derives de 4-oxo-4,6,7,8-tetrahydropyrrolo (1,2-a) pyrazine-6-carboxamides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DE102018220624A1 (de) * 2018-11-29 2020-06-04 B. Braun Melsungen Ag Wässrige Zusammensetzung, insbesondere zur Behandlung von Schleimhaut und/oder Wunden
US20250122225A1 (en) * 2023-10-06 2025-04-17 Omeros Corporation Masp-2 inhibitors and methods of use

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05117276A (ja) * 1991-10-23 1993-05-14 Sumitomo Pharmaceut Co Ltd 新規な３環性キノキサリンジオン誘導体
MD970253A (ro) * 1994-12-22 1999-05-31 Biochem Pharma Inc. Inhibitori biciclici micromoleculari ai trombinei
US6057314A (en) * 1995-12-21 2000-05-02 Biochem Pharma Inc. Low molecular weight bicyclic thrombin inhibitors
WO1997048706A1 (en) * 1996-06-18 1997-12-24 Warner-Lambert Company Pyrrolo[1,2-a]pyrazine-1,4-dione serine protease inhibitors
ES2191830T3 (es) * 1996-10-24 2003-09-16 Merck & Co Inc Inhibidores de trombina.
US6011038A (en) * 1997-09-05 2000-01-04 Merck & Co., Inc. Pyrazinone thrombin inhibitors
CA2348530A1 (en) * 1998-10-30 2000-05-11 Merck & Co., Inc. Thrombin inhibitors
UA58636C2 (uk) * 1999-06-04 2003-08-15 Мерк Енд Ко., Інк. Піразинонові інгібітори тромбіну, фармацевтична композиція, спосіб інгібування утворення тромбів у крові, спосіб лікування станів, пов'язаних із тромбоутворенням
FR2795072B1 (fr) * 1999-06-15 2001-07-27 Adir Nouveaux derives bicycliques d'amino-pyrazinones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
EP1215213A2 (fr) 2002-06-19
HUP0105328A3 (en) 2003-03-28
NO20016069L (no) 2002-06-17
HUP0105328A2 (hu) 2002-07-29
CY1106376T1 (el) 2011-10-12
DK1215213T3 (da) 2007-05-21
CA2364199A1 (fr) 2002-06-14
EP1215213B1 (fr) 2007-01-17
AU9723001A (en) 2002-06-20
SI1215213T1 (sl) 2007-04-30
CN1358723A (zh) 2002-07-17
KR20020048302A (ko) 2002-06-22
AR031662A1 (es) 2003-09-24
PT1215213E (pt) 2007-03-30
MXPA01012895A (es) 2002-11-07
HK1047101B (zh) 2005-10-28
FR2818277A1 (fr) 2002-06-21
EP1215213A3 (fr) 2002-09-25
US6686358B2 (en) 2004-02-03
KR100502251B1 (ko) 2005-07-22
JP3616599B2 (ja) 2005-02-02
US20020111341A1 (en) 2002-08-15
JP2002212184A (ja) 2002-07-31
NO322149B1 (no) 2006-08-21
CA2364199C (fr) 2007-04-10
CN1209363C (zh) 2005-07-06
EA004678B1 (ru) 2004-06-24
BR0106129A (pt) 2003-04-08
PL351199A1 (en) 2002-06-17
HU0105328D0 (en) 2002-02-28
HK1047101A1 (en) 2003-02-07
DE60126046T2 (de) 2007-11-29
NZ516129A (en) 2003-05-30
ES2280333T3 (es) 2007-09-16
ZA200110314B (en) 2003-03-12
AU781614B2 (en) 2005-06-02
EA200101204A1 (ru) 2002-06-27
FR2818277B1 (fr) 2003-01-24
DE60126046D1 (de) 2007-03-08

Similar Documents

Publication Publication Date Title
NO20022285L (no) Nye <alfa>-aminosyreforbindelser, fremgangsmÕte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20003764D0 (no) Nye <beta>-karbolinforbindelser, fremgangsmÕte ved deres fremstilling og farmasøytiske sammensetninger inneholdende dem
NO20021542L (no) Nye <alfa>-aminosyresulfonylforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdendedem
NO20013254L (no) Nye difenylureaforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske samensetninger som inneholder dem
NO20010522L (no) Nye piperidin-4-sulfonamidforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdendedem
NO20023662D0 (no) Nye heterocykliske derivater, fremgangsmåte ved fremstilling og farmasöytiske sammensetninger inneholdende det samme
NO20026154L (no) Nye substituerte ftalider, fremgangsmåte for deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20014945L (no) Nye cyklonbutendionforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20016069D0 (no) Nye bicykliske amino-pyrazinonforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdendedem
NO20013206L (no) Nye 1,1- og 1,2-disubstituerte cyklopropanforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiskesammensetninger inneholdende dem
NO20010305L (no) Nye benzensulfonamidforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20021198D0 (no) Nye isoindoloindolonforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20023345D0 (no) Nye oktahydro-2H-pyrido[1-2-a]pyrazinforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiskesammensetninger inneholdende dem
NO20031643D0 (no) Nye aminotriazolonforbindelser, fremgangsmåte for deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20021330D0 (no) Nye indenoindolonforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20013710L (no) Nye benzotiadiazinforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20023389D0 (no) Nye benzensulfonamid-forbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20023409D0 (no) Nye N-benzylpiperazinforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20011862D0 (no) Nye heterocykloalkylbenzocyklobutan- og heteroarylbenzocyklobutanforbindelser, fremgangsmåte ved deresfremstilling og farmasöytiske sammensetninger inneholdende dem
NO20021806L (no) Nye pyrimidin-4-on-forbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20010801D0 (no) Nye 6-amino- eller 6-hydroazino-sulfonyl-3- kinolynylfosfonsyreforbindelse, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20022794L (no) Nye indenoindolonforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20011863D0 (no) Nye cyklobutaindolkarboksamidforbindelser, fremgangsmåter ved deres fremstilling og farmasöytiske sammensetninger inneholdendedem
NO20020262L (no) Nye cykloheptenforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20010800L (no) Nye 6-sulfamoyl-3-kinolylfosfonsyreforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiskesammensetninger inneholdende dem